Table IV.

The results of ROC analysis for discriminating significant from subclinical coronary stenosis.

	AUC (95% CI)	p	HL chi2
hs-CRP	0.66 (0.52–0.79)	0.031	14.35*
PTX3	0.67 (0.54–0.81)	0.017	8.41*
hsCRP and PTX3	0.71 (0.57–0.85)	0.004	11.09*
Model 2	0.68 (0.54–0.81)	0.020	14.03*
Model 2 and hsCRP	0.71 (0.58–0.84)	0.006	6.85*
Model 2 and PTX3	0.71 (0.58–0.85)	0.005	33.54
Model 2, hsCRP and PTX3	0.74 (0.60–0.87)	0.002	7.25*
Model 3	0.69 (0.56–0.82)	0.013	8.54*
Model 3 and hsCRP	0.761 (0.63–0.89)	0.001	12.20*
Model 3 and PTX3	0.74 (0.61–0.88)	0.002	21.73
Model 3, hsCRP and PTX3	0.772 (0.64–0.90)	<0.001	13.29*

Hosmer-Lemeshow (HL) tests based on 10 groups.

^*Significant HL goodness of fit, p>0.05;

¹significantly different from model 2;

²significantly different from model 3.